☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Cidara
Jeff Stein, President & CEO of Cidara Therapeutics Shares Insights on the P-III ReSTORE Trial of Rezafungin to Treat Candidemia
August 30, 2022
Cidara Entered into a License Agreement with Melinta to Commercialize Rezafungin for Candidemia and Invasive Candidiasis in the US
July 28, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.